Trial Profile
Adoptive immune therapy of chemotherapy-refractory CMV-infection with Streptamer-selected T-cells after allogeneic bone marrow- or peripheral blood stem cell transplantation - AIT-CMV-Stage-01
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs T cell replacement therapy (Primary)
- Indications Cytomegalovirus infections; Graft-versus-host disease
- Focus Adverse reactions
- Acronyms AIT-CMV-Stage-01
- Sponsors Stage cell therapeutics
- 06 Sep 2011 New trial record